OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Advances in Lung Transplant
Submission Deadline: November 15, 2022 (Open) Submit Now
Shambhu Aryal, MD,FCCP
Inova Advanced Lung Disease an Lung Transplant Program, Inova Fairfax Medical Campus, 3300 Gallows Road, Falls Church, VA 22042, USA
Research Interests: Lung Transplantation; Interstitial Lung Disease; Sarcoidosis; Pulmonary Hypertension; Cystic Fibrosis
About This Topic
OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation. This is seeking original manuscripts for a Special Issue on: “Advances in Lung Transplant” scheduled to appear in the first half of 2023.
Lung transplantation is an established life-saving treatment for select patients who have failed conventional conservative medical therapy for their lung disease. After the first successful surgery in the early 1980s, the number of lung transplantations performed worldwide has increased steadily to about 5000 transplants per year. This increase in numbers has enriched the experience of the lung transplant community and led to several advances in the field. Improvement in surgical techniques and peri-operative management in the first couple of decades of lung transplantation led to improvement in early post-transplant survival. More recently, a lot of interest and resources are being put into important areas including primary graft dysfunction, organ preservation and rehabilitation, biomarkers in lung transplantation, antibody mediated rejection, and chronic lung allograft dysfunction. These works are expected to significantly improve both short-term and long-term outcomes including survival and quality of life for lung transplant recipient.
The special issue will provide a forum for presenting current research works and clinical results showing advancement in the field of lung transplantation noted above. The special issue will also be open to any author. Each submission will be reviewed by at least two reviewers to ensure a very high quality of papers selected for the Special Issue.
Lung transplantation; Acute cellular rejection; Antibody mediated rejection; Primary graft dysfunction; Donor derived cell-free DNA; Biomarkers for lung transplantation; Chronic lung allograft dysfunction; Bronchiolitis obliterans syndrome; Restrictive allograft syndrome; Extracorporeal photopheresis
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.